ARCHIVES

Insurer Declines To Cover Avastin For Breast Cancer, Institutes Review Procedure For Exceptional Cases

This article is from The Cancer Letter archive.

Vol. 37 No. 39 | October 21, 2011

Download PDF Visit The Full Archive

Related Articles

Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions

August 16, 1991

Recombinant Protein C Cuts Risk Of Sepsis Death

February 22, 2002

UCSF Gets $20 Million For Stem Cell Research Building

February 4, 2011

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995

ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number

June 17, 2011

Will Insurers Pay Patient Care Costs? Stay Tuned For Act II Of This Oncodrama

July 31, 1998